Management of Raktatisara( ulcerative colitis) with Ayurveda treatment

Multimodal Ayurvedic management of Raktatisara(Ulcerative colitis)- A clinical study

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017069

Enrollment

Registered

2019-01-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K519- Ulcerative colitis, unspecified

Interventions

Intervention1: MULTIMODAL AYURVEDA INTERVENTION CONTAINS ORAL MEDICNE AND FORMULATION AS UNDER 1.LODHRA,MUSTA Nagakesara 2. Udumbara twak kwath 3. Kutaja ghan vati 4. Vatsakadi vati 5. Udumbara t

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis will be confirmed with the sign & symptoms of Ulcerative colitis having in the patients. As per ayurveda sign and symptoms Atisara (increase frequency of motion) Sarakta mala pravriti (bloody diarrhoea) Trushna (excessive thirst) Shula (abdominal pain) Vidaha (burning sensation) Jwara (fever) Gudapaka (proctitis or inflammation and pus formation around the anus) Colonoscopy report and/or biopsy suggesting a confirmed diagnosis of Ulcerative colitis. Patients fulfilling the diagnostic criteria. Patients will be selected between 18 to 60 years of age irrelevant of gender.

Exclusion criteria

Exclusion criteria: Patient with complications i.e. anal fistula, colonic perforation, cancer. Severe anemia (hemoglobin Patients in remission period. Severe systemic illness like, uncontrolled diabetes mellitus (HbA1C >7.5), AIDS, hepatitis, cancer, tuberculosis, uncontrolled hypertension etc. Patients, contraindicated for basti.

Design outcomes

Primary

Measure	Time frame
CHANGES IN SIGN AND SYMPTOMS OF RAKTATISARA(ULCERATIVE COLITIS).Timepoint: 8 WEEKS	—

Secondary

Measure	Time frame
ASSESSMENT OF DISEASE SEVIARITY MONTREAL CLASSIFICATION OF SEVERITY OF ULCERATIVE COLITISTimepoint: 4 WEEKS AND 8 WEEKS	—

Countries

India

Contacts

Public ContactDr Hemaxi M Indrodiya

J S Ayurveda Mahavidyalaya

vddhavaldholakiya1910@gmail.com8980925520

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026